Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycosylphosphatidylinositol-anchored cell wall transfer protein 1 describes a type of protein modified by the addition of a GPI anchor, a lipid-linked oligosaccharide that tethers proteins to the outer leaflet of the cell membrane[1][4][5]. In fungi and plants, certain GPI-anchored proteins are enzymatically active and are essential in transferring proteins from the plasma membrane to the polysaccharide-rich cell wall; these are often classified within the Dfg5/GH76 enzyme families in fungi[2]. In plants and fungi, these proteins play key roles in cell wall biogenesis, cell wall organization, and adaptation to environmental stress, while in mammals, GPI-anchored proteins are more diverse, with functions in signaling, cell adhesion, and enzymatic activity, but the term “cell wall transfer protein” is not a recognized functional or nomenclature category in mammalian biology[3][4]. No single, widely accepted therapeutic target exists under this particular name, though inhibitors of GPI anchoring or function are of research interest in antifungal development[2][7]. Issues/Notes on term “Glycosylphosphatidylinositol-anchored cell wall transfer protein 1”: - Not a universal human or mammalian protein or receptor; likely refers to a class of GPI-anchored proteins in fungi/plants. - Not found as a unique standardized human gene/protein (such as in UniProt, HGNC). - Role is best known in fungi (e.g., Dfg5 family, GH76 subfamily enzymes), involving transfer of GPI-anchored proteins from plasma membrane to cell wall[2]. - GPI-anchored proteins are a large, structurally diverse class with different biological functions depending on the organism[4][5][7]. - Not considered a therapeutic target per se (in humans), though GPI anchor biosynthesis is a validated essential process in some pathogens[7]. Summary: “Glycosylphosphatidylinositol-anchored cell wall transfer protein 1” is not a uniquely defined, therapeutically targeted molecule in human or mammalian biology, but rather refers to a class of GPI-anchored proteins—some of which, in fungi and plants, are involved in cell wall modification, transfer, or anchoring processes[2][3]. The name is too generic and lacks specificity for drug targeting, and it is not recognized as a singular canonical target in current pharmacology or clinical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycosylphosphatidylinositol-anchored cell wall transfer protein 1.